Digital Health & Life Sciences

Daniel Oliver is a co-founder and the CEO of Rejuvenate Bio, a startup out of George Church’s Lab at Harvard Medical School pioneering gene therapy solutions for age-related chronic diseases. Rejuvenate Bio’s initial focus on cardiovascular health involves a groundbreaking “one-shot” treatment for heart disease and obesity. The company’s story…

Claus Torp Jensen leads Dell Medical School’s technology and data roadmap, ensuring state‑of‑the‑art, cohesive, secure, performant and cost‑effective capabilities that enable world‑class care, research and education. A seasoned health care technology executive, he brings deep expertise in digital transformation, data and artificial intelligence, enterprise integration, and mergers and acquisitions. Before…

Neda Razavi is the CEO of iSono Health, a company redefining breast cancer detection through the convergence of AI, robotics, and 3D ultrasound. Under her leadership, iSono is creating a new category of imaging that eliminates reliance on sonographers, delivers MRI-like 3D breast images in minutes, and brings advanced diagnostics…

Dr. Walley is the CEO of NEXT Life Sciences, a reproductive health platform company with flagship product Plan ATM, a non-hormonal, long-lasting, reversible on demand male contraceptive. Dr. Walley has over 30 years of Life Science business experience, having served as an Executive at Procter & Gamble, Gillette/Oral-B Laboratories and…